Adhesion events in angiogenesis

Current Opinion in Cell Biology

Volumn 13, Issue 5, 2001, Pages 563-568

  Eliceiri, B P ^a   Cheresh, D A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; INTEGRIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; THROMBOSPONDIN; TUMSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL ADHESION; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

EID: 0035479826     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00252-0     Document Type: Review

References (68)

1. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability
2. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis
3. Vascular endothelial (VE)-cadherin: Only an intercellular glue?
4. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin
5. Monoclonal antibody strategies to block angiogenesis
6. Integrin signaling
7. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins
8. Cell adhesion: Old and new questions
9. Interactions between mitogenic stimuli, or, a thousand and one connections
10. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors
11. Signaling networks linking integrins and rho family GTPases
12. Rho GTPases. Integrating integrin signaling
13. Integrins: Emerging paradigms of signal transduction
14. The extracellular matrix as a cell survival factor
15. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
16. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells
17. Matrix attachment regulates Fas-induced apoptosis in endothelial cells. A role for c-flip and implications for anoikis
18. Inhibition of angiogenesis and tumor growth by SCH221153, a dual αvβ3 and αvβ5 integrin receptor antagonist
19. Targeted antiangiogenic therapy for cancer using Vitaxin: A humanized monoclonal antibody to the integrin αvβ3
20. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
21. Normal development, wound healing, and adenovirus susceptibility in β5-deficient mice
22. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
23. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
24. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
25. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
26. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
27. Anti-angiogenic cues from vascular basement membrane collagen
28. Distinct antitumor properties of a type IV collagen domain derived from basement membrane
29. αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF
30. The synergistic activity of αvβ3 integrin and PDGF receptor increases cell migration
31. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain
32. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
33. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
34. Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding
35. Cell contact-dependent activation of α3β1 integrin modulates endothelial cell responses to thrombospondin-1
36. Definition of two angiogenic pathways by distinct αv integrins
37. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability
38. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin
39. Angiogenesis promoted by vascular endothelial growth factor: Regulation through α1β1 and α2β1 integrins
40. Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A
41. Embryonic mesodermal defects in α5 integrin-deficient mice
42. Mesodermal defects and cranial neural crest apoptosis in α5 integrin-null embryos
43. Integrin αvβ3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor α5β1
44. Ligand binding to monocyte α2β1 integrin activates the α2β1 receptor via the α5 subunit cytoplasmic domain and protein kinase C
45. The αvβ3 integrin regulates α5β1-mediated cell migration toward fibronectin
46. A molecular mechanism of integrin crosstalk: αvβ3 suppression of calcium/calmodulin-dependent protein kinase II regulates α5β1 function
47. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
48. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells
49. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers
50. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
51. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration
52. Interaction of endostatin with integrins implicated in angiogenesis
53. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
54. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
55. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
56. Identification of the anti-angiogenic site within vascular basement membrane-derived Tumstatin
57. The cell biology of thrombospondin-1
58. Endogenous regulators of angiogenesis - Emphasis on proteins with thrombospondin-type I motifs
59. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
60. Angiostatin binds ATP synthase on the surface of human endothelial cells
61. A peptidomimetic antagonist of the integrin αvβ3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy
62. Small molecule αv integrin antagonists: Novel anticancer agents
63. Preferential susceptibility of brain tumors to the antiangiogenic effects of an αv integrin antagonist
64. Antiangiogenic agents
65. Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines
66. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
67. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2
68. Disruption of matrix metalloproteinase 2 binding to integrin alpha v beta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo